Anti-HIV-1 activity of resveratrol derivatives and synergistic inhibition of HIV-1 by the combination of resveratrol and decitabine

Keyphrases

• Human Immunodeficiency Virus Type 1 (HIV-1) 100%
• Resveratrol 100%
• Decitabine 100%
• Synergistic Inhibition 100%
• Resveratrol Derivatives 100%
• Anti-HIV-1 Activity 100%
• Mutation Rate 40%
• HIV-1 mutation 40%
• Nucleoside Analogues 40%
• Ribonucleotide Reductase Inhibitors 40%
• Antiviral Activity 20%
• Infectivity 20%
• Mechanism of Action 20%
• Viral Replication 20%
• Hydroxylated 20%
• Ribonucleotide Reductase 20%
• Synthetic Derivatives 20%
• Chain Terminator 20%

Pharmacology, Toxicology and Pharmaceutical Science

• HIV 100%
• Anti-Human Immunodeficiency Virus 100%
• Resveratrol 100%
• Decitabine 100%
• Ribonucleotide Reductase 42%
• Nucleoside Analog 28%
• Antiviral Activity 14%
• Infection 14%

Biochemistry, Genetics and Molecular Biology

• Human Immunodeficiency Virus 1 100%
• Resveratrol 100%
• Decitabine 100%
• Mutation Rate 20%
• Ribonucleotide Reductase Inhibitor 20%
• Nucleoside Analog 20%
• Virus Replication 10%
• Antiviral Activity 10%
• Ribonucleotide Reductase 10%